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Abstract:  Currently, cardiac radiofrequency ablation (RFA) is guided by 
indirect signals.  We demonstrate optical coherence tomography (OCT) 
characterization of RFA lesions within swine ventricular wedges.  
Untreated tissue exhibited a consistent birefringence artifact within OCT 
images due to the organized myocardium, which was not present in treated 
tissue.  Birefringence artifacts were detected by filtering with a Laplacian of 
Gaussian (LoG) to quantify gradient strength.  The gradient strength 
distinguished RFA lesions from untreated sites (p=5.93x10-15) with a 
sensitivity and specificity of 94.5% and 86.7% respectively.  This study 
demonstrates the potential of OCT for monitoring cardiac RFA, confirming 
lesion formation and providing feedback to avoid complications.  
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1. Introduction  
1.1 Radiofrequency ablation 
Cardiac arrhythmias afflict millions of patients in the United States, resulting in frequent 
hospitalizations and high medical costs[1]. Radiofrequency ablation (RFA) is the standard of 
care to cure many arrhythmias. The goal of RFA is to target and eradicate the critical 
component of an abnormal reentrant circuit or abnormal ectopic site in the heart, while 
minimizing or avoiding damage to normal areas of the heart.  RFA has revolutionized the 
treatment of arrhythmias with over 80,000 procedures performed in the United States each 
year[2].  According to a 2002 report by the FDA, 95% of RFA procedures are acutely 
successful, 90% are chronically successful, and 2.5% have major complications. [3]  
However, the complication rates vary, depending on the type of arrhythmia which is targeted.  
Ablation of atrial flutter or atrial tachycardia had rare reported complications[3-5], whereas 
ablation of ventricular tachycardia had a 2-8% range of complication rates.[3, 6]   
The duration of RFA procedures may range from 2 to 8 hours, depending on the type of 
arrhythmia that is targeted.  Currently ablation is monitored by indirect means by changes in 
catheter-tissue contact temperature, impedance, and intracardiac electrograms.  A direct 
image of the cardiac tissue during RFA could help guide the precise application of energy, 
monitor the successful formation of a lesion, visualize early effects of overtreatment, and 
potentially decrease procedure time.  Reduction of procedure time would furthermore reduce 
radiation exposure to the patient and operator because the procedure is performed under 
fluoroscopy.  In short, RFA therapy could benefit greatly from real time direct imaging, 
because it could lead to decreased procedure time, fewer complications, and increased acute 
and chronic success rates. 
1.2 Monitoring radiofrequency ablation therapy 
Currently, RFA procedures utilize fluoroscopy, static images from computed tomography 
merged with fluoroscopy, and/or noncontact, three-dimensional reconstructed mapping to 
visualize the position of catheters in the heart.   Monitoring the delivery of RF energy to the 
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endocardium is only by indirect means; that is, from change in the amplitude of intracardiac 
electrograms, change in tissue temperature, and change in impedance, all of which are 
measured at the tip of the catheter. These indirect methods of monitoring may result in 
delivering more ablation lesions than necessary to cure the arrhythmia and may also prolong 
procedural time. 
There are other approaches under investigation to monitor and guide RFA therapy, including 
magnetic resonance imaging (MRI) [7, 8] and intracardiac echocardiography [9, 10]. MRI 
obtains a three dimensional anatomy of the heart that can be merged with voltage maps.  The 
MRI is utilized for pre-procedural planning and for post-procedural evaluation.  Gadolinium 
enhancement of the MRI images has been used post-procedurally to increase the contrast 
between ablated nonviable tissue formed by RFA lesions and viable tissue [8, 11]. However, 
MRI is limited because it does not provide real-time guidance. Recent studies have utilized 
non-contrast mediated MRI to characterize ablation lesions[12, 13]. Additionally, not all RFA 
patients can undergo MRI evaluation, because MRI is contraindicated in patients with 
implantable devices such as cardiac pacemakers or defibrillators.  Intracardiac 
echocardiography monitors RFA therapy in real time to assess catheter-tissue contact and  
contact angle[14].  Additionally, intracardiac echo may visualize restenosis of pulmonary 
vessels[14] and may allow titration of RFA energy to reduce the incidence of embolic events 
due to over-treatment of cardiac tissue[9] .  However, intracardiac echocardiography does not 
have sufficient contrast to visualize the formation of lesions.  
Radiofrequency ablation therapy is a standard of care for the treatment of specific 
arrhythmias, and this procedure would benefit significantly from a compact, high-resolution, 
real-time, image-based monitoring technology. We hypothesize that the emerging imaging 
technique of optical coherence tomography (OCT) can monitor the formation of lesions 
produced by cardiac radiofrequency ablation therapy.  In this manuscript, we aim to show that 
OCT can validate that a lesion has been made, by distinguishing radiofrequency (RF) treated 
from untreated cardiac tissue. 
1.3 Optical coherence tomography 
OCT provides real-time subsurface imaging of biological tissues with high spatial resolution 
(on the order of ten micrometers) in three dimensions in vivo[15].  Depth-gated signals are 
acquired using low-coherence interferometry.  OCT is extremely sensitive to backscattered 
light and is capable of imaging to depths of 1-2 mm in cardiac tissue[16, 17].  OCT has been 
used for intra-coronary imaging[18], imaging of the myocardium within animal models of 
arrhythmias[17, 19, 20], and analyzing myocardial fiber structure using image analysis[19, 
20].  In addition, OCT has been used to image laser aortic ablation, [21] laser ablation of 
brain, liver, kidney, lung and rectus abdominis muscles [22], laser ablation of the 
esophagus[23] and high intensity focused ultrasound (HIFU) ablation lesions in ventricular 
myocardium[24]. Previous studies have shown that the optical properties of heated 
myocardium (absorption, scattering and anisotropy coefficients) are significantly different 
from normal tissue [25-27] and that these optical properties can be extracted from OCT 
images [28] for the purpose of tissue classification. Birefringence is an optical property of 
highly organized tissue such as cartilage and muscle which results in modulation of the state 
of polarization of light propagating in the tissue.  Polarization-sensitive OCT (PSOCT) has 
been used to measure tissue birefringence to assess tissue damage due to ablation therapy[29, 
30].    Tissue birefringence can be observed as artifacts within conventional OCT images [31-
33].  These artifacts have been used previously to assess collagen content within 
atherosclerotic plaques[32]. 
OCT can potentially address unmet clinical needs of cardiac radiofrequency ablation 
therapy by assessing the contact and contact angle of the RF catheter with the tissue, 
confirming that a lesion has been formed when RF energy is delivered, detecting early 
damage, and identifying structures for procedural guidance.  Imaging to monitor tissue 
#117702 - $15.00 USD Received 28 Sep 2009; revised 21 Dec 2009; accepted 22 Dec 2009; published 28 Jan 2010
(C) 2010 OSA 1 February 2010 / Vol. 18,  No. 3 / OPTICS EXPRESS  3082
contact and contact angle can increase the efficiency of RF energy delivery. Acute success 
and efficacy of ablation are determined through functional electrophysiology (EP) testing, to 
ensure that the lesions interrupt conduction.  The ability to directly confirm that a lesion has 
been formed after energy delivery will eliminate ambiguity when EP testing shows that 
conduction interruption was not achieved, by eliminating the possibility the energy dose 
failed to result in a lesion.  The ability to detect early damage could enable titration of energy 
delivery and reduce complication rates.  
Here, we report that clinically relevant ablation lesions in ventricular myocardium in vitro 
can be distinguished from untreated tissue using OCT imaging, by detecting changes in tissue 
birefringence, optical properties, and tissue architecture.  We also observe that over-treated 
lesions exhibit additional characteristic features, and that gaps between lesions are detectable.  
This work sets the foundation for investigating the feasibility of real-time monitoring of RFA 
therapy using OCT.  While the axial field of view of OCT imaging is too small to encompass 
an entire RFA lesion, real time monitoring of RFA therapy with high-resolution imaging 
could provide direct visualization of the heart surface, visualization and confirmation of 
ablation lesion formation, and feedback to titrate RFA dosage to avoid complications and 
minimize procedure time. 
2. Methods  
2.1 In vitro ablation protocol 
Freshly excised ventricular wedges from swine hearts were used for in vitro characterization 
of ablation lesions with OCT imaging.  Following the onset of general anesthesia, a lateral 
thoracotomy was performed, and the heart was rapidly excised and placed in ice-cold 
phosphate buffered saline (PBS).  The right ventricular free wall, left ventricular free wall, 
and ventricular septum were dissected and placed in ice-cold PBS, up to 2 hours, until the 
start of RFA.  All animal studies were conducted according to protocols approved by the 
Institutional Animal Care and Use Committee of Case Western Reserve University.   
Dissected ventricular wedges were placed in a bath with PBS maintained at 37oC with 
super-perfusion flow (Figure 1-A). During the application of RF energy, all samples were 
submerged in 3 cm of PBS so that the RF catheter tip is completely submerged and operates 
normally.  It is standard clinical practice to create lesions using a temperature controlled 
protocol (50-70oC) by delivering RF energy for a fixed duration (e.g. 60 seconds), where the 
RF generator  controls RF power to reach and maintain the target temperature. For this study, 
a series of ablative lesions were created with a temperature controlled (70oC) protocol with a 
maximum delivered power of 50W and maximal duration of 60 seconds, using a clinical RFA 
generator (Maestro 3000, Boston Scientific). Endocardial lesions were created using a 7Fr, 
4mm tip catheter (Blazer II, Boston Scientific), applying RF energy for 10 seconds (n=19), 20 
seconds (n=22), 30 seconds (n=23), and 60 (n=28) seconds distributed over 7 hearts for a total 
of 92 lesions.  
An additional set of endocardial ablation lesions were created on ventricular tissue with 
the same temperature controlled protocol.  After creating ablation lesions, these samples were 
subsequently volumetrically imaged by OCT to test the ablility to identify of gaps within 
linear ablation lines. 
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 Figure 1. Experimental setup for in vitro characterization of ablation lesions using OCT.  A) In vitro radiofrequency 
ablation lesions created on excised ventricular wedges in a temperature controlled bath with super-perfusion flow. B) 
Gross pathology of ablative lesions on the endocardial surface of swine right ventricle. (Pins demarcate ends of 
ablative lesions) C) Optical coherence tomography (OCT) system.  D) Representative OCT image of a seven 
millimeter image of ablative lesion and adjacent tissue.  E) TTC stain of ablative lesion shown in panel (D).  White 
necrotic tissue of ablative lesion and red viable tissue are demonstrated. 
 
2.2 Optical coherence tomography imaging 
After administering RFA, a pair of pins was placed along the maximal dimension of each 
ablation lesion (Figure 1-B).  Imaging was conducted with a time-domain OCT system 
described previously[34] with a light source centered at1310 nm with a 70 nm bandwidth 
(Figure 1-C). The axial and lateral resolution of the system was approximately 10 and 18 
micrometers respectively (in air). Seven-millimeter OCT scans were recorded to encompass 
the lesion, and seven-millimeter control images were recorded of areas where no RFA energy 
was delivered (480 A-lines per image).  These data were used for the lesion detection study. 
Three dimensional image sets of ventricular wedges with RFA lesions were acquired with 
a microscope-integrated 1310nm Fourier Domain OCT (FDOCT) system.  The axial and 
lateral resolution of this system was approximately 10 micrometers (in air)[35].  Spectral 
interferograms were acquired with a linear in wavenumber (k=2π/λ) spectrometer[36] onto a 
1024 pixel line scan camera (Goodrich) spectrometer, acquired at 40 images per second (1000 
A-lines per image).  The system has a 2mm -6dB imaging range and 110dB signal-to-noise 
ratio. Three-dimensional image sets were 4 x 4 x 4.3 mm3 in dimension, with 400 images per 
volume.  These data were used to investigate the appearance of gaps  
2.3 Validation 
Staining with triphenyltetrazolium chloride (TTC) was used to identify necrosis and quantify 
lesion size. TTC is a vital stain for assessing dehydrogenase enzyme activity and has been 
widely used for assessing acute myocardial injury to differentiate necrosis from viable 
tissue[37].  Tetrazolium salts produce colored precipitates in the presence of an intact 
dehydrogenase system.  Necrotic tissue lacks dehydregease activity and fails to stain.  
.Directly after imaging, the tissue was sliced in the direction of the OCT B-scan, as indicated 
by the pins and incubated in 1.0% TTC in PBS for 20 minutes at room temperature. The TTC 
stained samples were digitized with a calibration marker.  Using the software package Image 
J (NIH), lesion depth, width, and area were recorded for each lesion.  
2.4 Image analysis 
Two main characteristics of OCT images of RFA lesions, compared to untreated tissue, were 
observed and targeted for quantitative analysis.  First, the intensity increases due to increased 
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scattering.  Second, the birefringence artifact is eliminated due to decreased tissue 
birefringence.  Image analysis tools were developed (using Matlab 7.4, Mathworks Inc.) to 
quantify these two parameters for the purpose of distinguishing ablation lesions from 
untreated tissue.  Preprocessing was conducted for each image to reduce noise by convolving 
with a 5 x 5 Wiener filter and removing the noise floor from the image. The images were 
flattened by detecting the tissue surface with using a threshold. Thereafter, each image was 
decimated to 190 x 24 pixels (Figure 2-a-c) to reduce computation and speckle noise in axial 
scans (Figure 2-g-i). The region of interest (ROI) analyzed was 525 microns in length in the 
axial dimension, starting 100 µm below the sample surface to avoid surface reflections and 
the endocardial layer.  The lateral region of interest was the entire 7mm image for untreated 
tissue, and the area in between the pins for treated tissue.  The intensity parameter was 
calculated as the mean intensity of the decimated and flattened OCT image within the ROI.   
 
 
Figure 2.  Dark band due to tissue birefringence  a-b) OCT images of an untreated site obtained with different 
polarization states of the sample arm light. .  Location of band moves as the polarization state in the sample arm is 
changed.  Birefringence dependent bands are highlighted with green arrows.  (Media 1) c) Representative OCT image 
of an ablation lesion. d-f) Decimated and flattened version of images shown in a-c.  Region of interest, 525µm, used 
in analysis shown in panel e as white horizontal lines.  g-j) Representative averaged axial scans from the sites 
indicated in e-h, shows change in location of the band within axial scans of untreated site (g and h).  No band in OCT 
image of ablation lesion. Images acquired with time domain (TDOCT) system. 
 
A dark band was consistently observed within images of untreated tissue (e.g. Figure 2-
a,b).  To demonstrate that the observed bands were birefringence artifacts and not tissue 
structures, a sample site was imaged while the polarization state of the sample arm light was 
changed using a polarization controller.  Figure 2 shows two images of the identical site 
illuminated by different polarization states.  It can be clearly observed that the band changes 
location in a polarization-dependent way.  
In order to automatically detect the birefringence artifact, a Laplacian of Gaussian (LoG) 
was implemented.  The LoG filter has been previously used to identify regions that are 
brighter or darker than their surroundings[38]. The LoG is a linear filter and is a combination 
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of a Laplacian operation and a Gaussian filter.  The Laplacian estimates the second derivative 
of the signal.  The Gaussian filter is used to smooth the data and reduce the contribution of 
noise to the second derivative. The parameters of the LoG are the kernel dimensions and the 
standard deviation for the Gaussian.   LoG with a 20x1 pixel kernel size and 0.5 pixel 
standard deviation was convolved with the flattened and decimated OCT image.  The gradient 
strength parameter, representing the presence of the birefringence artifact, was defined as the 
mean pixel value within the ROI of the LoG-filtered image.   
 
2.5 Statistical analysis 
Student t-tests and receiver operator characteristic curves (ROC) were used to determine 
whether the quantified tissue classification parameters can be used for binary differentiation 
of untreated tissue from TTC-confirmed RFA lesions.  Results are reported as mean (95% 
confidence interval).  The software package Origin 8.0 was used to conduct statistical 
analysis and a p-value less than 0.05 was considered statistically significant.   
3. Results  
A total of 92 images of lesions and 30 control images were distributed between the septum, 
right ventricle, and left ventricles of 7 swine hearts.  These images were analyzed with OCT 
imaging (Figure 1-C, D) and subsequently with TTC staining (Figure 1-E).  As shown in 
Figure 2, lesions created in this in vitro model follow the predicted trend where temperature 
increased over time, approaching the target temperature by 60 seconds.  Impedance decreased 
over time (Figure 3-B), and power remained roughly constant (Figure 3-C). This resulted in 
lesions depths, as determined by TTC, which increased as a function of RF energy delivery 
time (Figure 3-D).   Thus, the created lesions accurately modeled clinical RFA lesions. 
 
Figure 3.  A) Temperature duration curve.  Catheter-tissue temperature increased 
monotonically over time, up to a maximal temperature of 70 degrees Celsius. B) Impedance 
measurements during RF ablation.  Impedance measured at the catheter tissue interface 
decreased during RF applications, consistent with formation of lesions. C) Strength duration 
curve.  Power was consistent throughout the RF applications at 25 Watts.  D). Lesion 
development over time.  The depth of the lesion created by RF increased with longer duration 
of RF application. Results +/- 95% CI 
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 3.1 Tissue classification 
OCT images of untreated sites had a characteristic polarization-dependent band, due to the 




Figure 4.   Representative OCT images of untreated ventricular endocardium. Birefringence 
band is visible within images of untreated tissue (indicated by green arrows in panel A). Right 
ventricle (A,B),  left ventricle (C,D), and right ventricular septum (E,F).  Images acquired with 
time domain (TDOCT) system. 
 
 
RFA lesions (Figure 5) were characterized by increased intensity and an absence of a 
birefringence dependent polarization artifact band. 
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 Figure 5.   Representative OCT images of endocardial radiofrequency ablation lesions. Pins are 
placed along the ends of the lesion and are visible within OCT images.  Yellow dotted lines 
indicate the area of the RFA lesion. Ablation lesions are characterized by increased signal 
intensity and absence of polarization artifact.  Right ventricle (A,B),  left ventricle (C,D), and 
right ventricular septum (E,F).  Images acquired with time domain (TDOCT) system. 
 
To evaluate the ability of each image analysis parameter to distinguish lesions from 
untreated tissue, a receiver operator characteristic analysis was conducted.  The mean value of 
analysis parameters gradient strength and mean intensity for each site was used for analysis.  
The lateral region of interest for lesions was defined as the area between the pins. The area 
under the curve was largest for the gradient strength, 0.94. The gradient strength was 
significantly different between untreated samples 2.0 (0.25) and ablation lesions -1.2 (0.1), 
p=5.93x10-5. By choosing a threshold that produces the maximum accuracy, 0.78, the 
gradient strength had a high sensitivity and specificity, 94.5% and 86.7% respectively.  When 
analyzing the data according to tissue type, the gradient strength had an AUC of 0.99, 0.95, 
and 0.97 for the left ventricle, right ventricle, and ventricular septum and a sensitivity and 
specificity for the right ventricle (94.6%, 93.3%), left ventricle (96.4%, 100%) and ventricular 
septum (96.3%, 100%).  Mean intensity was significantly increased, p=2.82x10-4, between 
untreated samples 35.8 (1.7) and ablation lesions 43.5 (1.0).  However, mean intensity was 
not a strong classifying parameter with an AUC of 0.72 and a threshold of 28.7 that produces 
maximum accuracy resulted in a sensitivity of 94.6% and specificity of26.7%. This is 
demonstrated Figure 6, where the main parameter separating untreated sites from ablation 
lesions was the gradient strength.  
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Figure 6. Distinguishing ablation lesions and untreated tissue using gradient strength. a) Scatter 
plot for each image within the TDOCT dataset, with gradient strength on the x-axis and 
intensity on the y-axis.  Ablation lesions (open shapes), untreated tissue (filled shapes).  Left 
ventricle – circle, right ventricle – square, ventricular septum - triangle B) Receiver operator 
characteristic (ROC) curve for gradient strength to distinguish ablation lesions from untreated 
tissue.  Lesions can be distinguished from untreated samples within all sites using gradient 
strength as a discriminating factor, with a 0.94 area under curve (AUC).  C) ROC curve for 
intensity.  Intensity had a low classification power to distinguish ablation lesions from 
untreated tissue, with a 0.72 AUC. 
 
A mean 24W of RF energy was delivered to the wedges, resulting in an average lesion depth 
of 1.5 (0.10) mm and surface width of 4.5 (0.14) mm, determined by TTC staining.  The 
surface width indicated by the pins was 3.9 (0.08) mm. The width of ablation lesions 
confirmed by TTC vital staining was slightly larger (0.67 mm) than the distance between pins 
used to identify RFA lesions within OCT images.  Thus, the area used for analysis of RFA 
lesions within OCT images was confirmed to be necrotic tissue.  Image analysis parameters 
gradient strength and mean intensity did not show a relationship with lesion depth. 
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Within volumetric image sets of linear ablation lines, a gap of viable tissue between two 




Figure 7.  Gap of untreated tissue within linear ablation line characterized by band due to 
polarization artifact.  a) The gap of untreated tissue was characterized by a strong birefringence 
dependent band.  b)  TTC vital staining of ablation two ablation lesions with gap of untreated 
tissue. c) OCT image decimated to 512 x 13 pixels. d-f) Representative averaged axial scans 
from decimated image within areas with lesion (d,f) and untreated tissue (e).  Band is observed 
within area of treated tissue and not ablation lesions.  Images acquired with microscope 
integrated Fourier Domain (FDOCT) system.  
 
3.2 Visualization of overtreatment 
Within a subset of OCT images of RFA lesions (n=34), disruptions were visible within the 
myocardium (Figure 8).  These disruptions were attributed to over-treatment; however none 
of the procedures produced craters, tearing of the endocardial surface, or audible steam pops, 
indicative of endocardial or myocardial rupture. The standard measurements of mean 
temperature (p=0.997), impedance (p=0.467), and power (p=0.488), were not significantly 
different between lesions without visible disruptions and over-treated lesions.  
 
Figure 8. Representative OCT images of the endocardium with visualization of “over treated” 
RFA lesions. Disruptions within the endocardium and myocardium are visible, and may be 
precursors to steam pops and crater formation. Yellow dotted lines circumscribe each lesion. 
Images acquired with time domain (TDOCT) system. 
 
4. Discussion  
Radiofrequency ablation (RFA) causes thermal damage due to resistive heating, producing an 
area of coagulation necrosis[2].  Thermal damage of the myocardium has been shown to 
cause changes in the optical properties of tissue, in particular anisotropy coefficient, 
scattering coefficient[25-27], and birefringence[39].  Our results show that using a 
conventional, single detector, OCT system there are measurable tissue characteristics that are 
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markers of RFA lesion formation. This demonstrated the potential for the use of OCT to 
address an important unmet clinical need.  Image parameters related to changes in optical 
properties and tissue architecture can be used for binary discrimination of RFA lesions from 
the untreated myocardium. OCT image-derived parameters were used to differentiate 
untreated sites from RFA lesions.  
Viable myocardial tissue is birefringent, which resulted in a polarization-dependent 
banding artifact within OCT images. Tissue birefringence was lost within ablation lesions.  
This result is consistent previous observations using polarization-sensitive OCT (PSOCT) of 
thermally damaged skin and tendon where tissue birefringence was lost after heating [29].  
The birefringence artifact visible in OCT images of untreated myocardium provided an 
effective contrast mechanism between untreated tissue and non-birefringent ablation lesions.  
Therefore, with a conventional OCT system, accurate binary tissue classification was possible 
without explicitly quantifying tissue birefringence by use of the gradient strength parameter.  
Although the birefringence band’s location can vary between control samples, the gradient 
strength quantified the presence of the birefringence band and had a small variability within 
control samples. It is expected that use of PSOCT will improve detection of tissue 
birefringence, and also provide artifact-free images that will allow for additional analysis 
such as changes in tissue attenuation.  Therefore, in the future, we will evaluate the use of 
PSOCT to measure tissue scattering and birefringence to increase the accuracy of tissue 
classification.   
Previous work has shown that scattering increases within ablation lesions[25].  Because 
signal intensity is related to the scattering coefficient, we expected a higher mean signal 
intensity for ablated tissue compared to untreated tissue. Signal intensity increased 
significantly within all tissue types after RFA (p=2.82x10-4).  The absence of the 
birefringence dependent band within treated tissue may contribute to the significant increase 
in image intensity.   Therefore, increased signal intensity with the application of RF energy 
may be contributed to both an increase in scattering and an absence of the birefringence 
dependent band.  However, there may be intrinsic differences in optical properties between 
untreated tissue and ablation lesions that warrant further investigation.  The mean intensity 
within ventricular septum samples were significantly lower (p=0.002) than right and left 
ventricular samples.  Lesions created on the ventricular septum were conducted after 
experiments with the right and left ventricles were completed, but within the 2 hour period.  
Therefore, the ventricular septum was left in PBS longer before the start of RFA compared to 
right and left ventricles. This prolonged time within PBS may have contributed to the 
decreased intensity of the ventricular septum samples  
Disruptions within the myocardium were observed in a subset of OCT images, which we 
believe to be precursors to steam pops.  It is current practice to use the increase of tissue-
electrode impedance as a signal to detect overtreatment of the tissue and coagulum 
development[2].  However, previous studies have shown that adverse effects such as steam 
pops are not always associated with a large change in impedance[40].  More than ever, this is 
important for saline irrigated RFA catheters.  Intracardiac echocardiography has also been 
used to monitor ablation therapy, which may allow titration of RF energy to reduce incidence 
of embolic events due to over-treatment. This technique provides real-time monitoring, but 
relies on the visualization of microbubbles[9], an indirect measure of tissue state, to guide the 
treatment protocol. As demonstrated in Figure 8, high resolution, subsurface imaging using 
OCT can provide direct visualization of early damage to the myocardium, which may be 
precursors to steam pops and crater development.  This can potentially be a valuable tool to 
titrate RF dosage and reduce complications. 
This study demonstrates the potential for OCT to be used as a monitoring tool for cardiac 
RFA therapy.  Real time imaging modalities have potential clinical utility in monitoring and 
guiding RFA procedures by providing a visual of the heart-catheter interface, visualization of 
normal areas of the heart to avoid during ablation, validation that a lesion has been made, and 
#117702 - $15.00 USD Received 28 Sep 2009; revised 21 Dec 2009; accepted 22 Dec 2009; published 28 Jan 2010
(C) 2010 OSA 1 February 2010 / Vol. 18,  No. 3 / OPTICS EXPRESS  3091
detecting precursors to complications.  Our results do not provide evidence that OCT may be 
suitable for assessing depth of cardiac RFA lesions.  We demonstrated that OCT can be used 
to differentiate ablation lesions from untreated tissue and visualize potential complications 
due over treatment.  These results motivate the next step toward translation of this 
technology.  Future in vivo investigations will require catheter based imaging using PSOCT 
for assessing dynamics due to RF energy delivery. A contact OCT catheter will displace 
blood from the OCT field of view, allowing the OCT probe beam direct access to the tissue 
surface.  Saline irrigated RFA catheters are becoming standard during complex RFA 
procedures and could be used in combination with contact OCT catheters to further displace 
blood. A forward-imaging probe in contact with the tissue will largely mitigate motion 
artifacts during in vivo imaging.  High speed imaging will further mitigate motion artifact as 
well as any artifacts due to changes in myocardial optical properties as a function of time 
during the cardiac cycle.  This will enable future studies to evaluate the ability for OCT to 
discriminate viable tissue from ablation lesions in the presence of blood, with varying catheter 
contact angle, and in vivo.   Catheter-based imaging will allow for real-time monitoring 
during RF energy delivery, assessment of tissue contact, and observation of the time 
dependence of image analysis parameters to evaluate whether OCT guidance can identify 
early markers of complications and observe lesion formation in real time.   
5. Conclusion  
This study demonstrates that optical coherence tomography has the potential to monitor the 
formation of radiofrequency lesions in the heart.  Our experimental results validate that using 
OCT imaging, RFA lesions can be distinguished from the untreated endocardium.  Changes 
in optical properties and loss of birefringence provide intrinsic contrast between untreated 
tissue and ablation lesions. In addition, potential predictors of complications such as crater 
formation are visible within OCT images.   
A direct image by OCT has the potential to guide the precise application of energy, avoid 
normal cardiac structures where ablation could be harmful, ensure adequate tissue contact 
during energy delivery and provide real-time formation of successful lesions.   Importantly, 
this may decrease the procedure time and radiation exposure to the patient and physician.  
Furthermore, real-time feedback from OCT during RFA therapy may enable decreased 
complication rates. Therefore, these data set the foundation for OCT as an imaging modality 
for future real-time direct monitoring of cardiac RFA therapy. 
Acknowledgements 
The authors would like to thank Lee Barwick, Bryan Webb, and Dr. Steve Schomisch for 
technical assistance and Dr. David Rosenbaum for advice and consultation. The project was 
supported by the Wallace H. Coulter Foundation and by the National Institutes of Health 
(HL085939, HL083048, RR1246).  The content is solely the responsibility of the authors and 
does not necessarily represent the official views of the National Heart Lung and Blood 
Institute or the National Institutes of Health.  
 
#117702 - $15.00 USD Received 28 Sep 2009; revised 21 Dec 2009; accepted 22 Dec 2009; published 28 Jan 2010
(C) 2010 OSA 1 February 2010 / Vol. 18,  No. 3 / OPTICS EXPRESS  3092
